INRS research team makes a promising breakthrough in the fight against chronic infections
LAVAL, QC, July 24, 2025 /CNW/ - In fighting chronic infections or certain cancers, CD8+ T cells—the immune system's frontline soldiers—eventually become exhausted. They lose effectiveness and respond less efficiently to threats. This weakening is a major therapeutic challenge, as it limits the body's ability to fight chronic infections.
However, the team of Professor
These
A Key Ally Against T Cell Exhaustion
T cell exhaustion is caused by several factors, including an imbalance in internal cell functioning. Normally, T cells shift their energy production to respond quickly to infection. But when they are stimulated for too long—as during chronic infections—their metabolism becomes depleted. They produce fewer cytokines (chemical messengers essential to the immune response), their mitochondria (the cell's energy centres) function less efficiently, and they ultimately lose their effectiveness.
In this study, the team used the LCMV Clone 13 virus, a model of chronic infection, to explore the role of IRF-5 in CD8+ T cells. While the role of IRF-5 in other cell types is well known, its function in these immune cells had not been explored until now.
"Our results show that IRF-5 acts as a guardian of T cell metabolism and mitochondrial function. It helps T cells maintain their energy and ability to fight, even under prolonged stress."
—Simona Stäger, INRS professor and senior author of the study, expert in immunology of infectious diseases, and Vice-director of
The researchers found that the absence of IRF-5 worsens exhaustion. CD8+ T cells lacking IRF-5 showed disrupted lipid metabolism, increased mitochondrial oxidative stress, and reduced oxidative phosphorylation—all factors that impair their function.
A Promising Step Toward Better Understanding Immunity
This discovery opens the door to new strategies for boosting immunity to chronic infections or cancers, where T cell exhaustion is also observed.
"I hope our work will help us better understand how to modulate cellular metabolism to support and enhance immune responses during chronic infections or cancer. IRF-5 transcription factor could play a key role in this approach."
—Linh Thuy Mai, lead author of the study, former PhD student in virology and immunology from INRS, currently a postdoctoral fellow at Albert Einstein College of Medicine, United States.
Professor Stäger's laboratory is based at the
About the Study
The article, titled
This research was funded by the
About INRS
View original content to download multimedia:



